Skip to main content
New Website! ¡Nuevo sitio web!

ALERT: We have made the Texas Children’s Health Plan website even easier to use! Click here to learn more.

ALERTA: ¡Ahora el sitio web de Texas Children’s Health Plan es aún más sencillo de usar! Haz clic aquí para más información.

Enfamil shortage updates Escasez de Enfamil Reguline

ALERT: Shortage of Enfamil products until August 31, 2024. Learn more.

ALERTA: Escasez de productos de Enfamil hasta el 31 de agosto de 2024. Más información.

Change Healthcare Incident Change Healthcare incidente

Medicaid drug formulary changes

Attention: All Providers Effective Date: July 31, 2020 Providers should monitor the Texas Children’s Health Plan (TCHP) Provider Portal regularly for alerts and updates associated to the COVID-19 event.  TCHP reserves the right to update and/or change this information without prior notice due to the evolving nature of the COVID-19 event. Call to action: The Texas Vendor Drug Program (VDP) will implement changes to the state Medicaid drug formulary, effective Thursday, July 30, 2020. Select medications will be moving from “preferred” to “non-preferred” status and vice-versa. Texas Children’s Health Plan wanted to notify you in advance so that these changes do not impact the ability of your STAR and STAR Kids members to obtain their medications.  A summary of the changes is included below. How this impacts providers: Preferred and non-preferred medications may continue to require clinical prior authorizations. In addition to any clinical prior authorization requirements, non-preferred medications will also require a “step therapy prior authorization.” This means that STAR and STAR Kids members must have attempted and failed at least one preferred medication before obtaining a non-preferred medication. The preferred drug list (PDL) can be found on the VDP website: https://www.txvendordrug.com/formulary/prior-authorization/preferred-drugs. Medicaid managed care plans are required to follow the PDL. Next steps for providers:  Preferred drugs are medications recommended by the Texas Drug Utilization Review Board for their efficaciousness, clinical significance, cost effectiveness, and safety. Texas Children’s Health Plan encourages providers to initiate a preferred medication to members new to therapy. When possible, Texas Children’s Health Plan also encourages switching existing members to a preferred agent. Generics or alternatives with similar strengths/formulations available as preferred
PDL Drug ClassMedicationCurrent StatusStatus effective July 30, 2020Medications on Preferred Drug List
StimulantsAdderall XR 5 mg, 10 mg, 15 mg, 20 mg, 25 mg, 30 mg (oral)PreferredNon-preferred*Dextroamphetamine / Amphethamine ER 5 mg, 10 mg, 15 mg, 20 mg, 25 mg, 30 mg
StimulantsJornay PMNo statusNon-preferred*Methylphenidate CD, ER, LA
AnticonvulsantsLyrica capsule, solution (oral)PreferredNon-preferred*Pregabalin capsule, solution
Antidepressants, SSRIFluoxetine 60 mg (oral)PreferredNon-preferred*Fluoxetine 20 mg, 40 mg tablets
Antivirals, Oral/NasalTamiflu capsule (oral)PreferredNon-preferred*Oseltamivir capsule
PAH Agents, Oral and InhaledLetairis (oral)PreferredNon-preferred*Ambrisentan
Antiparkinson’s AgentsBromocriptine (oral)PreferredNon-preferredAmantadine, Benztropine, Carbidopa/Levodopa, Pramipexole, Ropinirole, Trihexyphenidyl
Prenatal VitaminsCitranatal DHA (oral)PreferredNon-preferredCitranatal 90 DHA,  Citranatal Assure, Citranatal B-Calm,  Citranatal Harmony,  Citranatal Rx Trinatal Rx 1
Prenatal VitaminsVol-Plus (oral)PreferredNon-preferredVitafol-OB Vitafol Ultra
Amino AcidsEndari powderNo statusNon-preferred
Antidiabetic AgentsRybelsusNo statusNon-preferredOzempic
Antihypoglycemia AgentsGvoke Hypopen, Gvoke PFSNo statusNon-preferredGlucagen, Glucagon
Antimigraine AgentsUbrelvyNo statusNon-preferredAimovig, Ajovy, Emgality
Sickle CellSiklos, OxbrytaNo statusNon-preferredDroxia, Hydrea, hydroxyurea
StimulantsDextroamphetamine / Amphethamine ER (oral)Non-preferredPreferred
Antidepressants, OtherVenlafaxine (oral)Non-preferredPreferred
Antivirals, Oral/NasalValcyte (solution)Non-preferredPreferred
Lipotropics, OtherFenofibrate capsule (Lofibra) (oral)Non-preferredPreferred
Lipotropics, StatinsRosuvastatin (oral)Non-preferredPreferred
PAH Agents, Oral and InhaledAmbrisentan (oral), Revatio suspension (oral)Non-preferredPreferred
Sedative HypnoticsEszopiclone (oral), Zaleplon (oral)Non-PreferredPreferred
Tardive DyskinesiaIngrezza (oral)Non-PreferredPreferred

 If you have questions, please contact us at tchppharmacy@texaschildrens.org.

For access to all provider alerts,log into: www.thecheckup.org or www.texaschildrenshealthplan.org/for-providers